Publications by authors named "W Loidl"

Claim this Profile
P
Pembrolizumab plus enzalutamide and androgen deprivation therapy versus placebo plus enzalutamide and androgen deprivation therapy for metastatic hormone-sensitive prostate cancer: the randomized, double-blind, phase III KEYNOTE-991 study.
C Gratzke, M Özgüroğlu, A Peer, M A N Sendur, M Retz, W Loidl

Ann Oncol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Ga]Ga-PSMA-11 PET/CT and [F]Fluorocholine PET/CT in Assessment and Clinical Decision Making of Recurrent Prostate Cancer: A Prospective Crossover Trial.
Mohsen Beheshti, Malihe Shahbazi-Akbari, Marcus Hacker, Wolfgang Loidl, Werner Langsteger

Mol Imaging Biol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nivolumab + Ipilimumab as Immunotherapeutic Boost in Metastatic Urothelial Carcinoma: A Nonrandomized Clinical Trial.
Marc-Oliver Grimm, Martin Schostak, Christine Barbara Grün, Wolfgang Loidl, Martin Pichler

JAMA Oncol· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Real-World Evidence of Triplet Therapy in Metastatic Hormone-Sensitive Prostate Cancer: An Austrian Multicenter Study.
Mona Kafka, Giulia Giannini, Nastasiia Artamonova, Hannes Neuwirt, Heidemarie Ofner, Wolfgang Loidl

Clin Genitourin Cancer· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Detection of Recurrence through microRNA-371a-3p Serum Levels in a Follow-up of Stage I Testicular Germ Cell Tumors in the DRKS-00019223 Study.
Gazanfer Belge, Cansu Dumlupinar, Tim Nestler, Markus Klemke, Peter Törzsök, Wolfgang Loidl

Clin Cancer Res· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis